广发纳斯达克生物科技人民币(001092)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2016-12-31 Alnylam Pharmaceuticals Inc 0.51%
2016-12-31 泰邦生物 0.46%
2016-12-31 Ultragenyx Pharmaceutical Inc 0.46%
2016-12-31 Syneos Health Inc-A 0.45%
2016-12-31 爱克龙药业 0.43%
2016-12-31 Intercept Pharmaceuticals Inc 0.43%
2016-12-31 Horizon Therapeutics plc 0.41%
2016-12-31 ARIAD Pharmaceuticals Inc 0.38%
2016-12-31 麦迪逊医药 0.38%
2016-12-31 蓝鸟生物 0.37%
2016-12-31 基立福 0.37%
2016-12-31 Kite Pharma Inc 0.35%
2016-12-31 Ligand Pharmaceuticals Inc 0.34%
2016-12-31 GW Pharmaceuticals plc ADR 0.33%
2016-12-31 Ironwood Pharmaceuticals Inc-A 0.32%
2016-12-31 Juno Therapeutics Inc 0.32%
2016-12-31 内克塔治疗 0.3%
2016-12-31 Sage Therapeutics Inc 0.3%
2016-12-31 Agios Pharmaceuticals Inc 0.28%
2016-12-31 Clovis Oncology Inc 0.27%

投资模拟

公告&资料